<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>PBL 2- Brucellosis by Celestine</title>
      <link>https://padlet.com/celestinehoh/6vzi1revb034</link>
      <description></description>
      <language>en-us</language>
      <pubDate>2017-10-17 06:41:21 UTC</pubDate>
      <lastBuildDate>2025-12-09 15:18:53 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>PBL 2: Diagnostic assay suitable to detect Brucellosis</title>
         <author>celestinehoh</author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/197657479</link>
         <description><![CDATA[<div>This is the link. Fore reference.. <a href="https://bmcresnotes.biomedcentral.com/articles/10.1186/1756-0500-4-525">https://bmcresnotes.biomedcentral.com/articles/10.1186/1756-0500-4-525</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-17 06:43:57 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/197657479</guid>
      </item>
      <item>
         <title>the diagnostic assays that can be used to diagnose the disease</title>
         <author>celestinehoh</author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/197657922</link>
         <description><![CDATA[<div>Although several serological tests can be used for the diagnosis of bovine brucellosis, the <strong>Rose Bengal plate test (RBPT) and the complement fixation test (CFT</strong>) are the official tests currently used for serologic diagnosis of the disease. RBPT is a simple plate agglutination test mainly used as a screening test in cattle. The low pH of the antigen prevents partial agglutination by IgM and then reduces non-specific reactions. CFT has been regarded as a specific confirmatory test especially because it detects almost only IgG1</div>]]></description>
         <enclosure url="http://www.tandfonline.com/doi/full/10.1080/09712119.2016.1222942" />
         <pubDate>2017-10-17 06:46:12 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/197657922</guid>
      </item>
      <item>
         <title>What type of immunity is the most important in the clearance of the infectious agent (ie: cellular-mediated vs. humoral immunity</title>
         <author>celestinehoh</author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/197660799</link>
         <description><![CDATA[<div>Based on the abstract in the review attached, should be cellular-mediated.&nbsp;<br>Brucella spp. can survive in macrophages and other host cells, Th-1 cellular immunity that enhances the bactericidal effects of phagocytic cells and the cytotoxic effects of lymphocytes is more important than humoral immunity in Brucella infection.&nbsp;</div>]]></description>
         <enclosure url="https://padletuploads.blob.core.windows.net/prod/80358621/af9a7c6cf748da7180846bf7d9398dd1/Host_immune_response_during_Brucella_infection.pdf" />
         <pubDate>2017-10-17 07:01:16 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/197660799</guid>
      </item>
      <item>
         <title>How effective is vaccination in controlling the disease?</title>
         <author>celestinehoh</author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/197663717</link>
         <description><![CDATA[<div>S19 and RB51 are the officially approved <em>B. abortus</em> vaccine strains more widely and successfully used to prevent bovine brucellosis worldwide. but there is still continuous development to obtain ideal vaccine to increase its efficacy and reduce its side effects</div>]]></description>
         <enclosure url="https://veterinaryresearch.biomedcentral.com/articles/10.1186/s13567-015-0199-7" />
         <pubDate>2017-10-17 07:18:27 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/197663717</guid>
      </item>
      <item>
         <title>Brucellosis Diagnostic Assay (AIK)</title>
         <author></author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/200471378</link>
         <description><![CDATA[<div><a href="https://www.msdvetmanual.com/reproductive-system/brucellosis-in-large-animals/brucellosis-in-cattle">https://www.msdvetmanual.com/reproductive-system/brucellosis-in-large-animals/brucellosis-in-cattle</a><br><br>Diagnosis is based on bacteriology or serology. <em>B abortus</em> can be recovered from the placenta but more conveniently in pure culture from the stomach and lungs of an aborted fetus. Most cows cease shedding organisms from the genital tract when uterine involution is complete. Foci of infection remain in some parts of the reticuloendothelial system, especially supramammary lymph nodes, and in the udder. Udder secretions are the preferred specimens for culture from a live cow.</div><div><br></div><div>Serum agglutination tests have been the standard diagnostic method. Agglutination tests may also detect antibodies in milk, whey, and semen. An ELISA has been developed to detect antibodies in milk and serum. When the standard plate or tube serum agglutination test is used, complete agglutination at dilutions of 1:100 or more in serum samples of nonvaccinated animals, and of 1:200 of animals vaccinated at 4–12 mo of age, are considered positive, and the animals are classified as reactors. Other tests that may be used are complement fixation, rivanol precipitation, and acidified antigen procedures.</div><div>Screening Tests:In official eradication programs on an area basis, the <em>Brucella</em> milk ring test (BRT) has effectively located infected dairy herds, but there are many false-positive tests. The brucellosis status of dairy herds in any area can be monitored by implementing the BRT at 3- to 4-mo intervals. Milk samples from individual herds are collected at the farm or milk processing plant. Cows in herds with a positive BRT are individually blood tested, and seropositive cows are slaughtered to determine herd status.Nondairy and dairy herds in an area may also be screened for brucellosis by testing serum samples collected from cattle destined for slaughter or replacements through intermediate and terminal markets, or at abattoirs. Reactors are traced to the herd of origin, and the herd is tested. The cost of identifying reactors by this method is minimal compared with that of testing cattle in all herds. Screening tests, including the brucellosis card (or rose bengal) test and plate test, may be used in markets and laboratories to identify presumptively infected animals, thus reducing the number of more expensive and laborious diagnostic tests.Brucellosis-free areas can be achieved and maintained, effectively and economically, by using the BRT on dairy herds and through market cattle testing. Adult cattle are sampled at the time of slaughter.Supplemental tests using sensitive screening methods may be used in cattle in which the brucellosis status is unclear. Use of a battery of these tests improves the probability of detecting infected cattle that have remained in some herds as possible reservoirs of infection. Supplemental tests are also used to clarify the results of plate or card tests, especially in serum samples from vaccinated cattle. These tests, which include complement fixation and rivanol precipitation, are designed to detect primarily the antibodies specifically associated with <em>Brucella</em> infection. Another supplemental diagnostic procedure is to test milk samples from individual udder quarters by serial dilution BRT, which can be used to detect chronic infection in udders of cows that may have equivocal serum test reactions.<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-25 15:43:36 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/200471378</guid>
      </item>
      <item>
         <title>Some read up on Brucellosis Immunity</title>
         <author></author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/200472301</link>
         <description><![CDATA[<div><a href="https://pdfs.semanticscholar.org/2e54/615a2171d0a3144c32c4cd58e9af401639a5.pdf">https://pdfs.semanticscholar.org/2e54/615a2171d0a3144c32c4cd58e9af401639a5.pdf</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-25 15:45:02 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/200472301</guid>
      </item>
      <item>
         <title>Brucellosis Immunology</title>
         <author></author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/200476033</link>
         <description><![CDATA[<div><strong><br></strong>Brucella abortus antigenic stimulation of the host immune system includes the Lipopolysaccharides (LPS) of its gram negative cell wall. Field strains and the S19 vaccine strains have an O-side chain LPS. The RB51 vaccine strain does not have an O-side chain. 8 different biovars exist and may be identified on phage biochemistry with monospecific antiserum. Cross reactions to other bacteria may occur (e.g. Yersinia, Chlamydophila, Coxiella).<br>The brucella bacteria typically enters the body through the mucous membranes (nose, mouth, conjunctiva), where the reticulo-endothelial system (macrophages) picks it up and drains it to the local lymphnodes. From here a bacteremia usually ensues which may be recurrent. The organism typically targets the synoviae of joints, the testes and seminal vesicles, the udder and the gravid uterus (erythitol sugar) which includes the endometrium, placenta and foetus. Cell destruction and inflammation occurs which may lead to abortion. Brucellae are intracellular bacteria that stimulate both the cellular and humoral immune systems.<br>The humoral immune component is driven by B-lymphocytes. Antigen Presenting Cells (macrophages) present brucella specific antigens to B-lymphocytes. Memory B-cells are formed as well as active Plasma cells that produce specific antibodies to neutralize Brucellae. These plasma cells die after a few days and the antibody titre starts dropping. Memory cells retain the immunity for future recognition of the pathogen. IgM is produced first (primary response) during the natural immune response, followed by IgG after a short lag period which reaches higher concentrations. IgM declines once IgG starts spiking. During vaccination IgM antibodies persists longer and reaches a greater peak than IgG (compared to normal infection). This phenomenon may be useful in differentiation of infected versus vaccinated cattle if paired serum samples are collected for serology (SAT test). Experience is needed in interpreting results.<br>The cellular immune component consists of macrophages and neutrophils. APC’s present Brucellae antigens to T-lymphocytes. T-Memory cells are formed, as well as active T-helper/ killer cells that are able to recognize Brucellae infected cells. These T-helper/ killer cells then attach to the infected cells and secrete mediators to attractk phagocytic cells (macrophages) to destroy the infected body cells. Cellular mediated immunity is a type-IV hypersensitivity reaction (principle that the brucellin intradermal test is based on, that works in similar fashion to the tuberculin intradermal test).</div>]]></description>
         <enclosure url="https://padletuploads.blob.core.windows.net/prod/193130058/fa810bb07ce63f4ed7132f84627a013a/Brucellosis_in_Cattle_Interim_Manual_for_the_Veterinarian____AHT___Sept2016_signed.pdf" />
         <pubDate>2017-10-25 15:51:27 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/200476033</guid>
      </item>
      <item>
         <title>OIE Diagnostic Assay for Brucella (AIK)</title>
         <author></author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/200484788</link>
         <description><![CDATA[<div><a href="http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.04_BRUCELLOSIS.pdf">http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.01.04_BRUCELLOSIS.pdf</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-25 16:06:51 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/200484788</guid>
      </item>
      <item>
         <title>Interesting info about Brucella (AIK)</title>
         <author></author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/200510554</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.slideshare.net/Varshneyrajat11/brucellosis-51275516" />
         <pubDate>2017-10-25 16:53:50 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/200510554</guid>
      </item>
      <item>
         <title> vaccine for brucellosis</title>
         <author></author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/201120384</link>
         <description><![CDATA[<div><a href="https://www.aphis.usda.gov/animal_health/animal_diseases/brucellosis/downloads/bruc-facts.pdf">https://www.aphis.usda.gov/animal_health/animal_diseases/brucellosis/downloads/bruc-facts.pdf</a><br><br> The brucellosis vaccine is called RB51. RB51 works by producing an immune response that increases the animal's resistance to the disease. The vaccine is a live product and must be administered only by an accredited veterinarian or State or Federal animal health official. Vaccination is not 100 percent effective in preventing brucellosis; it typically protects about 70- 80 percent of the vaccinated cattle from becoming infected by an average exposure. For best results, female calves should be vaccinated when they are between 4 months and 1 year old.&nbsp;<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-27 08:52:08 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/201120384</guid>
      </item>
      <item>
         <title>vaccination for brucellosis</title>
         <author></author>
         <link>https://padlet.com/celestinehoh/6vzi1revb034/wish/201153187</link>
         <description><![CDATA[<div><br><a href="http://cdn.intechopen.com/pdfs/34769/InTech-Brucellosis_vaccines_an_overview.pdf">http://cdn.intechopen.com/pdfs/34769/InTech-Brucellosis_vaccines_an_overview.pdf</a></div>]]></description>
         <enclosure url="" />
         <pubDate>2017-10-27 12:02:37 UTC</pubDate>
         <guid>https://padlet.com/celestinehoh/6vzi1revb034/wish/201153187</guid>
      </item>
   </channel>
</rss>
